These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26139381)

  • 21. Identification of novel loci associated with mycobacterial isoniazid resistance.
    Viswanathan G; Yadav S; Raghunand TR
    Tuberculosis (Edinb); 2016 Jan; 96():21-6. PubMed ID: 26786650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the proteasome accessory factor (paf) operon in Mycobacterium tuberculosis.
    Festa RA; Pearce MJ; Darwin KH
    J Bacteriol; 2007 Apr; 189(8):3044-50. PubMed ID: 17277063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
    Huang TS; Kunin CM; Shin-Jung Lee S; Chen YS; Tu HZ; Liu YC
    J Antimicrob Chemother; 2005 Dec; 56(6):1058-62. PubMed ID: 16204341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis.
    Pasca MR; Guglierame P; De Rossi E; Zara F; Riccardi G
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4775-7. PubMed ID: 16251328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
    Zimenkov DV; Kulagina EV; Antonova OV; Surzhikov SA; Bespiatykh IuA; Shitikov EA; Il'ina EN; Mikhaĭlovich VM; Zasedatelev AS; Griadunov DA
    Mol Biol (Mosk); 2014; 48(2):251-64. PubMed ID: 25850294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.
    Willby M; Sikes RD; Malik S; Metchock B; Posey JE
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5427-34. PubMed ID: 26100699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Characterization of Sirtuin-like Protein in Mycobacterium smegmatis.
    Gu L; Chen Y; Wang Q; Li X; Mi K; Deng H
    J Proteome Res; 2015 Nov; 14(11):4441-9. PubMed ID: 26375486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones.
    Yew WW; Chan E; Chan CY; Cheng AF
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):936-7. PubMed ID: 12365583
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level.
    Duan X; Li Y; Du Q; Huang Q; Guo S; Xu M; Lin Y; Liu Z; Xie J
    Sci Rep; 2016 Jan; 6():19695. PubMed ID: 26806099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis.
    Stephan J; Mailaender C; Etienne G; Daffé M; Niederweis M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4163-70. PubMed ID: 15504836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Role of Proteasome Accessory Factor-C in Resistance against Second Line Drugs in Mycobacteria.
    Narain A; Dubey RK; Verma AK; Srivastava A; Kant S
    J Lab Physicians; 2020 Dec; 12(4):250-262. PubMed ID: 33390674
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
    Sulochana S; Rahman F; Paramasivan CN
    J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs.
    Ren H; Liu J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):250-5. PubMed ID: 16377694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.
    van den Boogaard J; Semvua HH; van Ingen J; Mwaigwisya S; van der Laan T; van Soolingen D; Kibiki GS; Boeree MJ; Aarnoutse RE
    J Antimicrob Chemother; 2011 Aug; 66(8):1810-4. PubMed ID: 21642290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
    J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
    Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
    Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for the enrichment, isolation and validation of Mycobacterium smegmatis population surviving in the presence of bactericidal concentrations of rifampicin and moxifloxacin.
    Pradhan A; Swaminath S; Jakkala K; Ajitkumar P
    FEMS Microbiol Lett; 2021 Jul; 368(14):. PubMed ID: 34240144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of ROS levels in antibiotic-exposed mycobacterial subpopulations confers differential susceptibility.
    Nair RR; Sharan D; Sebastian J; Swaminath S; Ajitkumar P
    Microbiology (Reading); 2019 Jun; 165(6):668-682. PubMed ID: 31091187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.